132 related articles for article (PubMed ID: 37155642)
21. Urinary Pharmacokinetic Profile of Cannabidiol (CBD), Δ9-Tetrahydrocannabinol (THC) and Their Metabolites following Oral and Vaporized CBD and Vaporized CBD-Dominant Cannabis Administration.
Sholler DJ; Spindle TR; Cone EJ; Goffi E; Kuntz D; Mitchell JM; Winecker RE; Bigelow GE; Flegel RR; Vandrey R
J Anal Toxicol; 2022 May; 46(5):494-503. PubMed ID: 34089060
[TBL] [Abstract][Full Text] [Related]
22. The chemical composition of ethanolic extracts from six genotypes of medical cannabis (Cannabis sativa L.) and their selective cytotoxic activity.
Janatová A; Doskočil I; Božik M; Fraňková A; Tlustoš P; Klouček P
Chem Biol Interact; 2022 Feb; 353():109800. PubMed ID: 34995571
[TBL] [Abstract][Full Text] [Related]
23. Differential effects of cannabis extracts and pure plant cannabinoids on hippocampal neurones and glia.
Ryan D; Drysdale AJ; Pertwee RG; Platt B
Neurosci Lett; 2006 Nov; 408(3):236-41. PubMed ID: 16997463
[TBL] [Abstract][Full Text] [Related]
24. Opposite Roles for Cannabidiol and δ-9-Tetrahydrocannabinol in Psychotomimetic Effects of Cannabis Extracts: A Naturalistic Controlled Study.
Sainz-Cort A; Jimenez-Garrido D; Muñoz-Marron E; Viejo-Sobera R; Heeroma J; Bouso JC
J Clin Psychopharmacol; 2021 Sep-Oct 01; 41(5):561-570. PubMed ID: 34412109
[TBL] [Abstract][Full Text] [Related]
25. Probing the antioxidant activity of Δ
Hacke ACM; Lima D; de Costa F; Deshmukh K; Li N; Chow AM; Marques JA; Pereira RP; Kerman K
Analyst; 2019 Aug; 144(16):4952-4961. PubMed ID: 31318364
[TBL] [Abstract][Full Text] [Related]
26. The protocol for the Cannabidiol in children with refractory epileptic encephalopathy (CARE-E) study: a phase 1 dosage escalation study.
Reithmeier D; Tang-Wai R; Seifert B; Lyon AW; Alcorn J; Acton B; Corley S; Prosser-Loose E; Mousseau DD; Lim HJ; Tellez-Zenteno J; Huh L; Leung E; Carmant L; Huntsman RJ
BMC Pediatr; 2018 Jul; 18(1):221. PubMed ID: 29981580
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological Comparisons Between Cannabidiol and KLS-13019.
Brenneman DE; Petkanas D; Kinney WA
J Mol Neurosci; 2018 Sep; 66(1):121-134. PubMed ID: 30109468
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the Analgesic Effect of High-Cannabidiol-Content Cannabis Extracts in Different Pain Models by Using Polymeric Micelles as Vehicles.
Román-Vargas Y; Porras-Arguello JD; Blandón-Naranjo L; Pérez-Pérez LD; Benjumea DM
Molecules; 2023 May; 28(11):. PubMed ID: 37298776
[TBL] [Abstract][Full Text] [Related]
29. Source of cannabinoids: what is available, what is used, and where does it come from?
Specchio N; Pietrafusa N; Cross HJ
Epileptic Disord; 2020 Jan; 22(S1):1-9. PubMed ID: 31941643
[TBL] [Abstract][Full Text] [Related]
30. Menadione reduces rotenone-induced cell death in cerebellar granule neurons.
Isaev NK; Stelmashook EV; Ruscher K; Andreeva NA; Zorov DB
Neuroreport; 2004 Oct; 15(14):2227-31. PubMed ID: 15371739
[TBL] [Abstract][Full Text] [Related]
31. Cannabis sativa: Much more beyond Δ
Alves P; Amaral C; Teixeira N; Correia-da-Silva G
Pharmacol Res; 2020 Jul; 157():104822. PubMed ID: 32335286
[TBL] [Abstract][Full Text] [Related]
32.
Gildea L; Ayariga JA; Ajayi OS; Xu J; Villafane R; Samuel-Foo M
Molecules; 2022 Apr; 27(9):. PubMed ID: 35566019
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic Use of Δ9-THC and Cannabidiol: Evaluation of a New Extraction Procedure for the Preparation of Cannabis-based Olive Oil.
Morini L; Porro G; Liso M; Groppi A
Curr Pharm Biotechnol; 2017; 18(10):828-833. PubMed ID: 29189144
[TBL] [Abstract][Full Text] [Related]
34. Purified Cannabidiol, the main non-psychotropic component of Cannabis sativa, alone, counteracts neuronal apoptosis in experimental multiple sclerosis.
Giacoppo S; Soundara Rajan T; Galuppo M; Pollastro F; Grassi G; Bramanti P; Mazzon E
Eur Rev Med Pharmacol Sci; 2015 Dec; 19(24):4906-19. PubMed ID: 26744883
[TBL] [Abstract][Full Text] [Related]
35. Overview of cannabidiol (CBD) and its analogues: Structures, biological activities, and neuroprotective mechanisms in epilepsy and Alzheimer's disease.
Li H; Liu Y; Tian D; Tian L; Ju X; Qi L; Wang Y; Liang C
Eur J Med Chem; 2020 Apr; 192():112163. PubMed ID: 32109623
[TBL] [Abstract][Full Text] [Related]
36. Antioxidant and Neuroprotective Effects Induced by Cannabidiol and Cannabigerol in Rat CTX-TNA2 Astrocytes and Isolated Cortexes.
di Giacomo V; Chiavaroli A; Recinella L; Orlando G; Cataldi A; Rapino M; Di Valerio V; Ronci M; Leone S; Brunetti L; Menghini L; Zengin G; Ak G; Abdallah HH; Ferrante C
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443623
[TBL] [Abstract][Full Text] [Related]
37. Effects of cannabidiol (CBD) on the inhibition of melanoma cells
Burch R; Mortuza A; Blumenthal E; Mustafa A
J Immunoassay Immunochem; 2021 May; 42(3):285-291. PubMed ID: 33428525
[TBL] [Abstract][Full Text] [Related]
38. Anti-inflammation and gingival wound healing activities of Cannabis sativa L. subsp. sativa (hemp) extract and cannabidiol: An in vitro study.
Kongkadee K; Wisuitiprot W; Ingkaninan K; Waranuch N
Arch Oral Biol; 2022 Aug; 140():105464. PubMed ID: 35623115
[TBL] [Abstract][Full Text] [Related]
39. Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug.
Zuardi AW; Crippa JA; Hallak JE; Moreira FA; Guimarães FS
Braz J Med Biol Res; 2006 Apr; 39(4):421-9. PubMed ID: 16612464
[TBL] [Abstract][Full Text] [Related]
40. A randomised controlled trial of vaporised Δ
Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
